Home

ALS Investment Fund

ALS Investment Fund

The ALS Investment Fund supports and finances biotech companies that develop drugs and diagnostics for Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig’s disease. The ALS Investment Fund was initiated by Dutch ALS patients and is advised by a top-tier European VC firm, Life Sciences Partners. The ALS Investment Fund invests globally, but focuses on Europe and the US. The fund brings depth of disease-specific knowledge and a deep network in the space.
Investor Type:
VC Firm
HQ Location:
Netherlands
Investment Areas:
Biotechnology Research, Treating Neurological and Cognitive Disorders, Huntington's disease, Genetic Disorders, Neurodegenerative Diseases
Typical Investment:
Above €3M
Funding Stage:
Series A/B, Series C & Beyond
Contact Email:
[email protected]